+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Polymerase Chain Reaction Market - Forecasts from 2019 to 2024

  • ID: 4895670
  • Report
  • December 2019
  • Region: Global
  • 101 Pages
  • Knowledge Sourcing Intelligence LLP

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • GE Healthcare
  • Merck KGaA
  • Promega Corporation
  • Siemens Healthineers AG
The global polymerase chain reaction market is projected to expand at a CAGR of 7.71% over the forecast period. Polymerase chain reaction, or PCR, is a technique to make many copies of a specific DNA region in vitro and relies on a thermostable DNA polymerase, Taq polymerase, and requires DNA primers designed specifically for the DNA region of interest. Using PCR it is possible to generate thousands to millions of copies of a particular section of DNA from a very small amount of DNA and is a common tool that is routinely used in DNA cloning, medical diagnostics, and forensic analysis of DNA. PCR technique is based on the natural processes a cell uses to replicate a new DNA strand.

Five core ‘ingredients’ are required to set up a PCR i.e. the DNA template to be copied, primers, DNA nucleotide bases, Taq polymerase enzyme, and buffer. PCR involves a process of heating and cooling called thermal cycling which is carried out by a machine in three main stages Denaturing, Annealing and Extending. These three stages are repeated 20-40 times, doubling the number of DNA copies each time. After PCR has been completed, electrophoresis can be used to check the quantity and size of the DNA fragments produced. PCR is used in many areas of biology and medicine, including molecular biology research, medical diagnostics, and even some branches of ecology.

Polymerase Chain Reaction market is anticipated to witness remarkable growth during the given forecast period. The growth in the market may be attributed to the rising use of polymerase chain reactions in clinical diagnostics and drug development. Technological advancements in the PCR techniques will also positively impact the market during the given forecast period. However, the high cost of the instruments required for Polymerase chain reactions might hamper the growth of the market during the given time frame.

By Product Type

By product type, the global Polymerase Chain Reaction (PCR) Market is segmented as Reagents, Instruments, Consumables and Software. Reagents section is expected to hold a significant share owing to the high consumption of the reagents and availability of different types of tests that require multiple types of reagents. Rising innovation in the reagent specificity will also boost the market for the segment during the given forecast period.

By End Users

In terms of end-user, the global Polymerase Chain Reaction (PCR) market is segmented as Pharmaceuticals and Biopharmaceutical Companies, Diagnostic Labs and Research Institutes. The pharmaceutical and biotechnology industry segment is expected to witness steady growth during the given time frame. The growth may be attributed to the continuous development in the pharmaceutical and biotechnology industries.

By Geography

Geographically, the Polymerase Chain Reaction (PCR) market is segmented as North America, South America, Europe, Middle East and Africa, and Asia Pacific. North America accounted for a significant market share in 2018 due to the rising incidence of various types of cancer and metabolic diseases that demand advanced diagnosis and therapies. Early adoption of the technology in the region will also boost the adoption of the PCR in the region. Asia Pacific is projected to witness the fastest regional market growth during the forecast period. Improved health care infrastructure and rising investment in healthcare and in life science research will fuel the growth of the PCR market in this region.

Segmentation

The Polymerase Chain Reaction (PCR) market has been segmented by product type, application, end-users, and geography.

By Product Type
  • Reagents
  • Instruments
  • Consumables
  • Software

By Application
  • Clinical Diagnosis
  • Forensic Laboratories
  • Life Science Research
  • Others

By End Users
  • Pharmaceuticals and Biopharmaceutical Companies
  • Diagnostic Labs
  • Research Institutes

By Geography

North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others

Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others

Middle East and Africa
  • Saudi Arabia
  • Israel
  • UAE
  • Others

Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Others
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • GE Healthcare
  • Merck KGaA
  • Promega Corporation
  • Siemens Healthineers AG

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Polymerase Chain Reaction (PCR) Market Analysis, by Product Type
5.1. Introduction
5.2. Reagents
5.3. Instruments
5.4. Consumables
5.5. Software
6. Polymerase Chain Reaction (PCR) Market Analysis, by Application
6.1. Introduction
6.2. Clinical Diagnosis
6.3. Forensic Laboratories
6.4. Life Science Research
6.5. Others
7. Polymerase Chain Reaction (PCR) Market Analysis, by End User
7.1. Introduction
7.2. Pharmaceuticals and Biopharmaceutical Companies
7.3. Diagnostic Labs
7.4. Research Institutes
8. Polymerase Chain Reaction (PCR) Market Analysis, by Geography
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. Israel
8.5.3. UAE
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. South Korea
8.6.4. India
8.6.5. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Thermo Fisher Scientific
10.2. Abbott Laboratories
10.3. Agilent Technologies, Inc.
10.4. Siemens Healthineers AG
10.5. Becton, Dickinson and Company
10.6. Promega Corporation
10.7. bioMérieux SA
10.8. Merck KGaA
10.9. Bio-Rad Laboratories, Inc.
10.10. GE Healthcare
11. Appendix
Note: Product cover images may vary from those shown
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Promega Corporation
  • bioMérieux SA
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
Note: Product cover images may vary from those shown